Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.57 - $48.1 $941,224 - $1.12 Million
23,200 Added 464.0%
28,200 $1.21 Million
Q2 2024

Aug 14, 2024

SELL
$44.56 - $62.43 $748,608 - $1.05 Million
-16,800 Reduced 77.06%
5,000 $226,000
Q1 2024

May 15, 2024

BUY
$55.44 - $63.8 $774,940 - $891,796
13,978 Added 178.7%
21,800 $1.36 Million
Q4 2023

Feb 14, 2024

SELL
$43.67 - $57.07 $34,936 - $45,656
-800 Reduced 9.28%
7,822 $438,000
Q3 2023

Nov 14, 2023

BUY
$51.65 - $65.54 $98,135 - $124,526
1,900 Added 28.27%
8,622 $454,000
Q2 2023

Aug 14, 2023

SELL
$52.7 - $64.12 $63,240 - $76,944
-1,200 Reduced 15.15%
6,722 $431,000
Q1 2023

May 15, 2023

SELL
$49.5 - $65.92 $242,203 - $322,546
-4,893 Reduced 38.18%
7,922 $423,000
Q4 2022

Feb 14, 2023

BUY
$44.83 - $57.43 $242,082 - $310,122
5,400 Added 72.83%
12,815 $685,000
Q3 2022

Nov 14, 2022

BUY
$46.07 - $60.1 $341,609 - $445,641
7,415 New
7,415 $342,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.